We are an ISO 9001-13485-14001-45001 and IATF 16949 certified company with a very experienced, outstanding technical team that can do extensive thermal and electrical modeling and analysis hand-in-hand with our customers

II-VI’s thermoelectrics for air-to-air or air-to-cold-plate heat exchanger systems allow for immunoassay reagent cooling, in vitro diagnostic specimen temperature control, genome sequencing reagent cooling, genome sequencing temperature cycling of sample slides, DNA fluidic sample temperature cycling, and general cooling units for the storage and transportation of insulin, tissue, and human organs. The TECs are quiet, with no moving parts; operate on low-voltage DC; and can be sealed to meet required sanitary specifications. This versatility enables precise temperature control of the cold plate or cold-side air stream and can provide both heating and cooling by simply switching the polarity of the DC voltage.

II-VI’s ability to design complete liquid- or air-cooled TEC assemblies that are optimized for available space, power, and thermal/electrical performance requirements including transient and temperature uniformity enables customers to develop world-class molecular diagnostic instrument platforms that are used for disease detection, including COVID-19. “Our long-term market experience allows us to understand our customers’ challenges and address them from day one of our working relationship, allowing for rapid and synchronized product development and enabling our customers to meet key scheduled milestones,” Townsend explained.

For medical applications, II-VI’s thermoelectrics are integrated into air-to-liquid heat exchangers to provide temperature-controlled fluids for several applications including blood/plasma transport or storage, laser cooling systems, physical rehabilitation pads, patient whole-body cooling/heating blankets, and burn trauma treatment systems. The TECs are integrated into systems that sandwich the TEC with a heat sink on one side and a liquid-filled exchanger on the other, allowing for precise temperature control of the fluid. A customer control scheme can be programmed to provide infinite fluid temperature control across the system’s entire heating and cooling range.

With nearly 50 years of business expertise and more than 30 years of experience in the life sciences and medical industries, II-VI recognizes that reliability and performance are critical aspects for the development of world-class instrumentation. With manufacturing options in the U.S. and Asia (Vietnam) along with a global supply chain reach, II-VI is uniquely able to optimize and reduce supply chain and production costs for its customers.

“Our extensive experience in developing and integrating reliable thermoelectric devices into life sciences and medical equipment applications remains a valued advantage for our customers,” said Townsend. During the current COVID-19 situation, for example, many companies are struggling to keep up with current market demands. II-VI is continuously developing and expanding its manufacturing capacity to support a customer base that is delivering analytic tools to support the pandemic. “We are working closely with our customers to ramp production and supply chain to meet the rapidly increasing demand for PCR and sequencing equipment to support COVID-19 testing. Our global operations, sales, and engineering teams are committed to delivering solutions that address COVID-19. Such engagement supports our corporate mission of enabling the world to be safer, healthier, closer, and more efficient,” concluded Townsend.